View drug registration information details.
Items | Registration information |
ID | 624 |
No | 624 |
Brand Name | URIEF TABLETS 4 MG |
Ingredients | SILODOSIN 4 MG |
Dosage Form | FILM COATED TABLET |
Primary Packaging | PVC-ALU BLISTER |
Storage | STOREIN A TIGHT CONTAINER PROTECTED FROM LIGHT AT ROOM TEMPERATURE NOT EXCEEDING 30 C |
Shelf Life | 3 YEARS |
Pack Size | BOX OF 3 X 10'S |
Dispensing Category | Prescription only |
ATC Classification | G04CA04 |
Pharmaceutical Class | ALPHA ADRENORECEPTOR ANTAGONISTS |
Indications | BLADDRER OUTLET OBSTRUCTION ASSOCIATED WITH BENIGNPROSTATIC HYPERPLASIA |
Contraindications | PATIENT WITH KNOWN HYPERSENSITIVITY TO ANY OF THE COMPONENTS OF URIEF TABLET 4 MG |
Side Effects | ABNORMAL EJACULATION, THIRST, STOMATITIS, STOMACH DISCOMFORT, DIARRHEA, LOOSE STOOLS, CONSTIPATION, DIZZINESS, LIGHT-HEADED FEELING, HEADACHE, EPISTAXIS, NASAL CONGESTION |
Unit Price | |
EDL |
No |
Description | WHITE TO PALE YELLOWISH- WHITE,OVAL, BICONVEX, SCORED FILM COATED TABLET IMPRINTED K ON ONE SIDEAND KD4 ON THE OTHER SIDE OF SCORE AND WITH THE SAME IMPRINT ON BOTH SIDES OF THE TABLET |
Note | |
License Owner | DKSH LAOS COMPANY LIMITED |
Manufacturer | KISSEI PHARMACEUTICAL CO.,LTD |
Country | THAILAND |
Import Registration No | 1B 1/56(N) |
Import Registration Date | 14-09-2016 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2020-09-18 |
FDD Registration No | 01 I 5376/23 |
FDD Registration Date | 2023-01-23 |
Expiry Date | 2026-01-22 |
Back to drug list
|